|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.75 SAR | -0.21% |
|
+2.80% | -1.32% |
| 11-18 | Kepler Cheuvreux Reduces Nahdi Medical's PT, Affirms Buy Rating | MT |
| 11-03 | HSBC Trims Nahdi Medical PT, Affirms Buy Rating | MT |
EPS & Dividend: Nahdi Medical Company
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | 5.5 | 5.5 | 5.425 | 5.732 | 6.103 |
| Rate of return | - | 4.01% | 4.68% | 5.79% | 6.11% | 6.51% |
| EPS 2 | 6.83 | 6.87 | 6.31 | 6.357 | 6.844 | 7.362 |
| Distribution rate | - | 80.1% | 87.2% | 85.3% | 83.8% | 82.9% |
| Reference price 2 | 167.20 | 137.00 | 117.60 | 93.75 | 93.75 | 93.75 |
| Nbr of stocks (in thousands) | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | - |
| Announcement Date | 20/03/23 | 17/03/24 | 10/03/25 | - | - | - |
Past dividends: Nahdi Medical Company
| 12/08/2025 | Interim Payment 2.6 SAR |
| 17/03/2025 | Final Payment 3 SAR |
| 11/08/2024 | Interim Payment 2.5 SAR |
| 23/03/2024 | Final Payment 3 SAR |
| 12/08/2023 | Interim Payment 2.5 SAR |
| 28/03/2023 | Final Payment 3 SAR |
| 15/08/2022 | Interim Payment 2.31 SAR |
Upcoming events: Nahdi Medical Company
| 15/03/2026 | Q4 2025 Earnings Release (Projected) |
| 12/05/2026 | Q1 2026 Earnings Release (Projected) |
| 04/08/2026 | Q2 2026 Earnings Release (Projected) |
| 03/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| 5.79% | 6.11% | 14.75x | 4.64x | 1.34x | ||
| -.--% | -.--% | 37.83x | 3.17x | 2.24x | ||
| -.--% | -.--% | 39.83x | 5.04x | 2.36x | ||
| 1.82% | 2.03% | 18.01x | 1.91x | 0.82x | ||
| 2.85% | 3.19% | 22.85x | 10.18x | 1.49x | ||
| 2.64% | 2.94% | 15.97x | 2.32x | 1.02x | ||
| 3.02% | 3.58% | 18.01x | 2.78x | 0.69x | ||
| 2.67% | 3.36% | - | - | 0.35x | ||
| - | - | 46.43x | - | - | ||
| 1.6% | 1.89% | 25.13x | 4.83x | 0.77x | ||
| Average | 2.27% | 2.57% | 26.53x | 4.36x | 1.23x | |
| Weighted average by Cap. | 1.11% | 1.25% | 31.78x | 4.02x | 1.77x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















